TY - JOUR
KW - Animals
KW - Dapsone
KW - Drug Resistance, Microbial
KW - Drug Therapy, Combination
KW - Humans
KW - leprosy
KW - Mice
KW - Rifampin
AU - Girdhar B K
AU - Desikan K V
AB - <p>Lepromatous patients of "Introductory Rifampicin therapy' (Lepr. India, 50: 1978) who received 300 mg Rifampicin daily for 3 months followed by 50-100 mg DDS daily for another 21 months are investigated for persisters in the skin. Mouse foot pad results revealed that at the end of 2 years of treatment viable M. leprae are still persisting in 3 out of 6 patients.</p>
BT - Leprosy in India
C1 - http://www.ncbi.nlm.nih.gov/pubmed/7278139?dopt=Abstract
CN - Infolep Library - available
DA - 1981 Jul
IS - 3
J2 - Lepr India
LA - eng
N2 - <p>Lepromatous patients of "Introductory Rifampicin therapy' (Lepr. India, 50: 1978) who received 300 mg Rifampicin daily for 3 months followed by 50-100 mg DDS daily for another 21 months are investigated for persisters in the skin. Mouse foot pad results revealed that at the end of 2 years of treatment viable M. leprae are still persisting in 3 out of 6 patients.</p>
PY - 1981
SP - 350
EP - 3
T2 - Leprosy in India
TI - Persister M. leprae after introductory rifampicin followed by dapsone therapy.
VL - 53
SN - 0024-1024
ER -